Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fibroses, Pulmonary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00953706
What this trial is testing

Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Homozygous for the F508del-CFTR Mutation

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 140
Not applicableStudy completedNCT04564664
What this trial is testing

High-flow Oxygen Therapy During Exercise in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Parc de Salut Mar 10
Early research (Phase 1)Study completedNCT06135363
What this trial is testing

Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Guangzhou JOYO Pharma Co., Ltd 45
Not applicableStudy completedNCT01818206
What this trial is testing

Bacteriophage Effects on Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
University Hospital, Montpellier 59
Testing effectiveness (Phase 2)Ended earlyNCT03287414
What this trial is testing

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 30
Testing effectiveness (Phase 2)UnknownNCT05424887
What this trial is testing

Evaluate the Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. 105
Not applicableUnknownNCT06431555
What this trial is testing

Magnetic Resonance Lung Function Imaging Study of Pulmonary Fibrosis Combined With Emphysema Syndrome

Who this might be right for
Using Functional Lung MRI to Explore Pulmonary Perfusion Changes in Patients With Pulmonary Fibrosis and Emphysema Syndrome
Beijing Chao Yang Hospital 55
Not applicableLooking for participantsNCT06654752
What this trial is testing

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

Who this might be right for
Cystic Fibrosis
University of Washington, the Collaborative Health Studies Coordinating Center 430
Not applicableStudy completedNCT04400955
What this trial is testing

Web and Tablet-based Interactive Audiometry in Adults With CF

Who this might be right for
Hearing Loss, SensorineuralCystic Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 156
Not applicableStudy completedNCT01883037
What this trial is testing

Comparing Laboratory Blood Glucose Results With HemoCue Glucose 201 RT

Who this might be right for
Cystic Fibrosis
Royal Brompton & Harefield NHS Foundation Trust 70
Not applicableActive Not RecruitingNCT06222905
What this trial is testing

Analysis of Remote Monitoring/Virtual Clinic Data in Adult Patients With Cystic Fibrosis (Project Breathe)

Who this might be right for
Cystic Fibrosis
Papworth Hospital NHS Foundation Trust 475
Testing effectiveness (Phase 2)Study completedNCT04006873
What this trial is testing

Gut Imaging for Function & Transit in Cystic Fibrosis Study 2

Who this might be right for
Cystic Fibrosis
Nottingham University Hospitals NHS Trust 12
Not applicableStudy completedNCT00863694
What this trial is testing

Fecal Calprotectin in Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Medical College of Wisconsin 106
Large-scale testing (Phase 3)Ended earlyNCT00879229
What this trial is testing

ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Gilead Sciences 40
Testing effectiveness (Phase 2)WithdrawnNCT00878761
What this trial is testing

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

Who this might be right for
Chronic Allograft Dysfunction
Stromedix, Inc. 48
Post-approval studies (Phase 4)WithdrawnNCT00625469
What this trial is testing

Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan

Who this might be right for
Pulmonary Arterial HypertensionIdiopathic Pulmonary Fibrosis
Rajan Saggar
Not applicableStudy completedNCT03190031
What this trial is testing

Respiratory Muscle Training in CF Patients

Who this might be right for
Cystic FibrosisRespiratory Muscles
University Hospital, Grenoble 38
Not applicableStudy completedNCT06350461
What this trial is testing

Impact of Discontinuing Hypertonic Saline in People With CF on Highly Effective CFTR Modulators- A SIMPLIFY Sub-Study

Who this might be right for
Cystic Fibrosis
Nicole Hamblett 370
Large-scale testing (Phase 3)Ended earlyNCT03267108
What this trial is testing

Assess Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis at Risk for Pulmonary Hypertension

Who this might be right for
Pulmonary FibrosisPulmonary Hypertension
Bellerophon Pulse Technologies 145
Early research (Phase 1)Study completedNCT02468908
What this trial is testing

Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects

Who this might be right for
Pulmonary Alveolar ProteinosisBronchiectasisCystic Fibrosis+1 more
Savara Inc. 42
Next Page